Mapping from the International Classification of Diseases (ICD) 9th to 10th Revision for Research in Biologics and Biosimilars Using Administrative Healthcare Data-Reference-Cited by-同舟云学术

Mapping from the International Classification of Diseases (ICD) 9th to 10th Revision for Research in Biologics and Biosimilars Using Administrative Healthcare Data

Published:2019-12-18 Issue:7 Volume:29 Page:770-777
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

He Mengdong¹^ORCID,Santiago Ortiz Adrian J.¹,Marshall James²,Mendelsohn Aaron B.²,Curtis Jeffrey R.³,Barr Charles E.⁴,Lockhart Catherine M.⁴^ORCID,Kim Seoyoung C.¹^ORCID

Affiliation:

1. Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital Harvard Medical School, Boston Massachusetts

2. Department of Population Medicine Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston Massachusetts

3. Division of Immunology and Rheumatology University of Alabama at Birmingham, Birmingham Alabama

4. Biologics and Biosimilars Collective Intelligence Consortium, Academy of Managed Care Pharmacy, Alexandria Virginia

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.4933

Reference46 articles.

1. ICD‐10.The Centers for Medicare & Medicaid Services (CMS).https://www.cms.gov/medicare/coding/icd10/. Accessed March 2 2019.

2. International Classification of Diseases (ICD‐10‐CM/PCS) Transition ‐ Background. The Centers for Disease Control and Prevention (CDC).https://www.cdc.gov/nchs/icd/icd10cm_pcs_background.htm. Accessed March 2 2019.

3. Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study

4. Cardiovascular (CV) Risk after Initiation of Abatacept versus TNF Inhibitors in Rheumatoid Arthritis Patients with and without Baseline CV Disease

5. Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic distinctions in depression and anxiety: a comparative analysis of comorbid and isolated cases;Psychological Medicine;2023-07-05

2. The US Food and Drug Administration Sentinel System: a national resource for a learning health system;Journal of the American Medical Informatics Association;2022-09-12

3. Associations Between Depression, Anxiety, and Multiple Disease Outcomes: A Phenotype x Phenome-Wide Association Study in Electronic Health Records;2022-06-04

4. Risk of cardiovascular events in patients having had acute calcium pyrophosphate crystal arthritis;Annals of the Rheumatic Diseases;2022-05-25

5. Acute myocardial infarction: Development and application of an ICD-10-CM-based algorithm to a large U.S. healthcare claims-based database;PLOS ONE;2021-07-01